Northwich’s Dechra Pharmaceuticals see group revenue increase by 12%
Northwich-based Dechra Pharmaceuticals, a manufacturer of veterinary products, has seen group revenue increase by 12%
This is due to group sales increasing by 59% in the USA, with sales in Europe increasing by 7%.
The group report that trading has been solid and finances remain in line with what was expected.
CEO, Ian Page, said: “The positive momentum experienced during the end of the last financial year has been maintained.
“On the strength of our recent revenue growth, we will accelerate investment in our sales and marketing infrastructure, particularly in the US as we look to strengthen our market presence.
“We remain confident that the execution of our strategy will continue to deliver future value.”
This was posted in Bdaily's Members' News section by Sophia Taha .